Stool test may predict gut healing in ulcerative colitis
NCT ID NCT07721441
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study is testing whether a simple stool test can predict if the gut lining is healing in people with moderate-to-severe ulcerative colitis who are starting biologic therapy for the first time. Researchers will measure levels of a protein called calprotectin in stool samples using a new method. The goal is to see if early changes in this protein can tell doctors whether the treatment is working, potentially reducing the need for invasive colonoscopies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fecal calprotectin test using magnetic particle chemiluminescence
- What this could lead to
- If successful, this could provide a non-invasive way to predict whether biologic therapy is healing the gut lining in ulcerative colitis, potentially reducing the need for frequent colonoscopies.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not test a new therapy. The results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chongqing General Hospital
Chongqing, Chongqing Municipality, 401121, China
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
-
Qilu Hospital (Qingdao), Shandong University
Qingdao, Shandong, 266035, China
-
Shengjing Hospital of China Medical University,
Shengyang, Liaoning, 110004, China
-
Shenzhen Hospital, Southern Medical University
Shenzhen, Guangdong, 518101, China
-
Tangdu Hospital, Air Force Medical University
Xi’an, Shanxi, 710038, China
-
The First Affiliated Hospital of Xi'an Medical University
Xi’an, Shanxi, 710077, China
-
The Second Hospital of Dalian Medical University
Dalian, 116023, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
-
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, 210009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New staining technique could sharpen healing assessment in IBD
- Real-World study tests Once-Daily pill for ulcerative colitis in chinese adults
- Can a higher dose of upadacitinib rescue ulcerative colitis patients when standard treatment fails?
- Study aims to keep workers with chronic illnesses on the job
- Real-World study tests Mirikizumab's power against ulcerative colitis
- New oral drug INT-210 aims to tame ulcerative colitis Flare-Ups